Date: August 8, 2024 By:
The Ragon Institute is delighted to have been featured in this Forbes profile of Phillip Ragon, who helped create the Ragon Institute and whose commitment to advancing medical research drives our mission forward. We are proud to share his story and the impact of his legacy on global health (Subscription required):
Researchers at the University of Amsterdam, in collaboration with the Batista Lab at the Ragon Institute, have developed a potential new approach for an HIV vaccine.
Researchers at the Ndhlovu Lab, part of the Ragon Institute and the Africa Health Research Institute (AHRI), have completed a significant study on the safety and practicality of lymph node excisions for HIV cure research in South Africa.
We spoke to Kim to learn more about her background, her research journey, and her experiences at the Ragon Institute over the past few months.